Sintx Technologies, Inc. (SINT)
Sintx Technologies, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Salt Lake City, UT, US. The stock last traded at $1.63, down 7.91% on the session, giving a market capitalisation of $10.4M. On trailing twelve-month figures it carries a trailing P/E of -0.30, a net margin of -1370.5%. Its beta of 0.64 implies it has historically moved less than the broad market.
Sintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative products serve biomedical, industrial, and antipathogenic uses, primarily marketed across the United States. Its diverse portfolio includes solid and porous silicon nitride, silicon nitride powder, and specialized coating products, along with advanced silicon nitride composite materials and polyetherketoneketone. Established in 1996, this company, once known as Amedica Corporation, has its corporate headquarters situated in Salt Lake City, Utah.
Sintx Technologies, Inc. is most often compared with the following Healthcare names: